Pneumoxytol® Ampoules for Aerosol
Medical Device • 10 ampoules for aerosol
CE-marked medical device indicated for the restoration and maintenance of the
physiological conditions of the mucosae and tissues of the respiratory system altered in
chronic bronchial inflammatory conditions.
At a glance
Essential information, available to companies, healthcare professionals and patients.
Category
Medical Device
CE 1370
Form
10 ampoules • 3 ml
Solution for aerosol
Composition
Myo-inositol
+ sodium chloride
What is Pneumoxytol® Ampoules
Pneumoxytol® ampoules are a CE-marked medical device indicated for the restoration and maintenance of physiological conditions of the mucosa and tissues of the respiratory tract altered in chronic bronchial inflammatory conditions, such as asthma and chronic obstructive pulmonary disease (COPD).
It is also indicated for the restoration and maintenance of the physiological conditions of the mucosa and tissues of the respiratory tract altered by environmental pollutants, cigarette smoke, or other agents. PNEUMOXYTOL® is indicated for the treatment of symptoms related to disorders of the upper respiratory tract, such as: oropharyngitis in both acute and chronic phases, hoarseness, and cough of post-viral irritative origin; influenza-like syndromes or common cold; and post-operative ENT conditions.
Reduction of respiratory insufficiency syndrome in premature newborns.
Indications for use
- Chronic obstructive pulmonary disease (COPD) and asthma
- Influenza-like syndromes or common cold
- Post-operative ENT conditions
- Oropharyngitis, hoarseness, cough
Composition
Each 3 ml ampoule contains:
Myo-inositol 400 mg
Instructions for use
It is recommended to use 1 ampoule of 3 ml, or,
according to medical advice,
up to a maximum of 3
ampoules per day.
Do not exceed the recommended dose.
Regulatory information
CE-marked medical device 1370. Carefully read the warnings and instructions for use.
Ministry of Health authorisation dated 23/01/2026.